Zedpenem 1 Injection contains Meropenem 1000 mg, a broad-spectrum carbapenem antibiotic indicated for the treatment of serious bacterial infections caused by susceptible strains of microorganisms. It exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Zedpenem 1 Injection is effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic pathogens, including multidrug-resistant strains. It is commonly employed in the management of complicated intra-abdominal infections, bacterial meningitis, septicemia, complicated skin and soft tissue infections, and lower respiratory tract infections such as pneumonia. The drug is administered intravenously, ensuring rapid systemic distribution and optimal therapeutic levels. Dosage and duration of therapy should be guided by the severity of infection, renal function, and susceptibility profile of the causative organism. Meropenem is generally well tolerated; however, potential adverse effects include hypersensitivity reactions, gastrointestinal disturbances, and transient elevations in liver enzymes. Caution is advised in patients with a history of beta-lactam allergy. Zedpenem 1 Injection should be used under strict medical supervision, with appropriate microbiological monitoring to prevent resistance development.